AAREY DRUGS & PHARMACEUTICALS Financial Statement Analysis
|
||
|
The Revenues of AAREY DRUGS & PHARMACEUTICALS have increased by 19.19% YoY .
The Earnings Per Share (EPS) of AAREY DRUGS & PHARMACEUTICALS has decreased by -15.57 % YoY. |
||
AAREY DRUGS & PHARMACEUTICALS Last 5 Annual Financial Results
[BOM: 524412|NSE : AAREYDRUGS]
| Standalone | Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 |
|---|---|---|---|---|---|
| Revenues | ₹474 Cr | ₹398 Cr | ₹419 Cr | ₹493 Cr | ₹348 Cr |
| Expenses | ₹471 Cr | ₹391 Cr | ₹411 Cr | ₹481 Cr | ₹344 Cr |
| Operating Profit (Excl OI) | ₹2.90 Cr | ₹6.48 Cr | ₹7.72 Cr | ₹11 Cr | ₹4.65 Cr |
| Other Income | ₹9.81 Cr | ₹4.94 Cr | ₹2.73 Cr | ₹2.67 Cr | ₹7.02 Cr |
| Interest | ₹4.66 Cr | ₹4.38 Cr | ₹2.87 Cr | ₹2.04 Cr | ₹2.44 Cr |
| Depreciation | ₹1.95 Cr | ₹1.70 Cr | ₹1.57 Cr | ₹1.99 Cr | ₹0.92 Cr |
| Profit Before Tax | ₹6.10 Cr | ₹5.34 Cr | ₹6.01 Cr | ₹10 Cr | ₹8.30 Cr |
| Profit After Tax | ₹4.02 Cr | ₹4.68 Cr | ₹3.77 Cr | ₹6.56 Cr | ₹6.51 Cr |
| Earnings Per Share (Rs) | ₹1.41 | ₹1.67 | ₹1.49 | ₹2.58 | ₹2.79 |
| PAT Margin (%) | 0.85 | 1.18 | 0.90 | 1.33 | 1.87 |
| ROE(%) | 3.02 | 3.82 | 3.33 | 6.31 | 6.98 |
| ROCE(%) | 6.38 | 6.09 | 6.28 | 9.87 | 9.46 |
| Total Debt/Equity(x) | 0.26 | 0.24 | 0.33 | 0.13 | 0.19 |
Key Financials |
||
| Market Cap | : | ₹ 255.2 Cr |
| Revenue (TTM) | : | ₹ 414.7 Cr |
| Net Profit(TTM) | : | ₹ 4.2 Cr |
| EPS (TTM) | : | ₹ 1.4 |
| P/E (TTM) | : | 61.1 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| AAREY DRUGS & PHARMACEUTICALS | -0.3% | 4.7% | 23.1% |
| ADANI ENTERPRISES | 1.3% | -3.6% | 35.5% |
| PREMIER ENERGIES | -2.8% | -7.7% | 3.9% |
| ADITYA INFOTECH | -6.4% | -7.4% | 228% |
| AEGIS LOGISTICS | -5.2% | -2.7% | 73.1% |
| REDINGTON | -5.4% | 20.8% | 42.4% |
| RRP SEMICONDUCTOR | -3.9% | -19% | 5618.4% |
| HONASA CONSUMER | 5.3% | 6.9% | 82.2% |
| LLOYDS ENTERPRISES | -7.4% | -3.5% | -1.9% |
AAREY DRUGS & PHARMACEUTICALS Revenues
[BOM: 524412|NSE : AAREYDRUGS]
| Y-o-Y | 19.19 % |
| 5 Yr CAGR | 8.00 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2025 | ₹474 Cr | 19.19 | |
| Mar2024 | ₹398 Cr | -5.09 | |
| Mar2023 | ₹419 Cr | -14.98 | |
| Mar2022 | ₹493 Cr | 41.43 | |
| Mar2021 | ₹348 Cr | - | |
AAREY DRUGS & PHARMACEUTICALS Operating Profit
[BOM: 524412|NSE : AAREYDRUGS]
| Y-o-Y | -55.28 % |
| 5 Yr CAGR | -11.15 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹2.90 Cr | -55.28 | |
| Mar2024 | ₹6.48 Cr | -16.06 | |
| Mar2023 | ₹7.72 Cr | -32.25 | |
| Mar2022 | ₹11 Cr | 145.02 | |
| Mar2021 | ₹4.65 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -62.58 % |
| 5 Yr CAGR | -17.71 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2025 | 0.61% | -62.58 | |
| Mar2024 | 1.63% | -11.41 | |
| Mar2023 | 1.84% | -20.35 | |
| Mar2022 | 2.31% | 73.68 | |
| Mar2021 | 1.33% | - | |
AAREY DRUGS & PHARMACEUTICALS Profit After Tax
[BOM: 524412|NSE : AAREYDRUGS]
| Y-o-Y | -14.09 % |
| 5 Yr CAGR | -11.35 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.02 Cr | -14.09 | |
| Mar2024 | ₹4.68 Cr | 24.21 | |
| Mar2023 | ₹3.77 Cr | -42.47 | |
| Mar2022 | ₹6.56 Cr | 0.63 | |
| Mar2021 | ₹6.51 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -27.97 % |
| 5 Yr CAGR | -17.89 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2025 | 0.85 % | -27.97 | |
| Mar2024 | 1.18 % | 31.11 | |
| Mar2023 | 0.9 % | -32.33 | |
| Mar2022 | 1.33 % | -28.88 | |
| Mar2021 | 1.87 % | - | |
AAREY DRUGS & PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 524412|NSE : AAREYDRUGS]
| Y-o-Y | -15.57 % |
| 5 Yr CAGR | -15.69 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2025 | ₹1.41 | -15.57 | |
| Mar2024 | ₹1.67 | 12.08 | |
| Mar2023 | ₹1.49 | -42.25 | |
| Mar2022 | ₹2.58 | -7.53 | |
| Mar2021 | ₹2.79 | - | |
AAREY DRUGS & PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 524412|NSE : AAREYDRUGS]
| Y-o-Y | 4.76 % |
| 5 Yr CAGR | -9.38 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2025 | 6.38% | 4.76 | |
| Mar2024 | 6.09% | -3.03 | |
| Mar2023 | 6.28% | -36.37 | |
| Mar2022 | 9.87% | 4.33 | |
| Mar2021 | 9.46% | - | |
AAREY DRUGS & PHARMACEUTICALS Share Price vs Sensex
| Current Share Price | : | ₹82.6 |
| Current MarketCap | : | ₹ 255.2 Cr |
| Updated EOD on | : | Aug 14,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AAREY DRUGS & PHARMACEUTICALS | -0.3% |
4.7% |
23.1% |
| SENSEX | -0.6% |
1.1% |
-3.2% |
AAREY DRUGS & PHARMACEUTICALS related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about AAREY DRUGS & PHARMACEUTICALS Financials
How the annual revenues of AAREY DRUGS & PHARMACEUTICALS have changed ?
The Revenues of AAREY DRUGS & PHARMACEUTICALS have increased by 19.19% YoY .
How the Earnings per Share (EPS) of AAREY DRUGS & PHARMACEUTICALS have changed?
The Earnings Per Share (EPS) of AAREY DRUGS & PHARMACEUTICALS has decreased by -15.57 % YoY .
Check out Intrinsic Value of Peers of AAREY DRUGS & PHARMACEUTICALS
|
Intrinsic Value of ADANI ENTERPRISES LTD Intrinsic Value of PREMIER ENERGIES LTD Intrinsic Value of ADITYA INFOTECH LTD Intrinsic Value of AEGIS LOGISTICS LTD Intrinsic Value of REDINGTON LTD |
Compare Stock Analytics of Peers of AAREY DRUGS & PHARMACEUTICALS
ADANI ENTERPRISES LTD vs PREMIER ENERGIES LTD vs ADITYA INFOTECH LTD
AEGIS LOGISTICS LTD vs REDINGTON LTD vs
ADANI ENTERPRISES LTD vs PREMIER ENERGIES LTD vs ADITYA INFOTECH LTD
AEGIS LOGISTICS LTD vs REDINGTON LTD vs
